HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

California’s Proposed Toxic Free Cosmetics Act Put On Ice After Industry Lobbying Blitz

Executive Summary

The bill, which would deal a serious blow to industry’s preservatives palette and prohibit any trace of lead in cosmetics, failed to advance out of committee April 9, roughly one week after the Personal Care Products Council and other industry reps descended on Sacramento to lobby against the measure.

You may also be interested in...



California’s Proposed Toxic-Free Cosmetics Act Revived As 2020 Begins

Cosmetic products in California that contain at least one of more than a dozen listed ingredients or contaminants – or any others selected by the health department going forward – would be adulterated and thus unlawfully marketed under the proposed Toxic-Free Cosmetics Act.

CIR Working To Highlight Expert Panel’s Independence Amid Mounting Pressures

The Cosmetic Ingredient Review says it expects to finalize a package of “advancements” in early 2020 to highlight the independence of its Expert Panel. Driven by the Personal Care Products Council-led CIR Steering Committee, the initiative comes at a time of escalating NGO criticism and legislative proposals that would undermine the CIR program and put its future in question.

California Fragrance Disclosure Bill Screeches To Halt As Legislature Adjourns For Year; Now What?

Funding issues appear to have factored in the proposed Cosmetic Fragrance and Flavor Ingredient Right to Know Act’s failure to cross the finish line in the first act of the California legislature’s 2019-2020 session. Far from popular with industry stakeholders, SB 574 nevertheless could represent a lesser-of-evils compromise of strategic importance, with further activity expected on the bill in 2020.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS148712

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel